Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126362361 | 12636236 | 1 | I | 20141207 | 20160721 | 20160809 | 20160809 | EXP | FR-FRI-1000086623 | FOREST | 82.67 | YR | F | Y | 0.00000 | 20160809 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126362361 | 12636236 | 1 | PS | MILNACIPRAN | MILNACIPRAN | 1 | Oral | 1 DF | 22256 | 1 | DF | CAPSULE | QD | ||||||
| 126362361 | 12636236 | 2 | SS | TARDYFERON | FERROUS SULFATE | 1 | Unknown | 2 TABLETS/DAY (ONE IN THE MORNING AND EVENING) | U | 0 | 2 | DF | TABLET | QD | |||||
| 126362361 | 12636236 | 3 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 1 DF | 0 | 1 | DF | QD | |||||||
| 126362361 | 12636236 | 4 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | 2 DF | Y | 0 | SOLUTION FOR INJECTION | ||||||||
| 126362361 | 12636236 | 5 | C | AMLOR | AMLODIPINE BESYLATE | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126362361 | 12636236 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | 0.5 DF | 0 | .5 | DF | QD | ||||||||
| 126362361 | 12636236 | 7 | C | CALCIDOSE | CALCIUM CARBONATE | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126362361 | 12636236 | 8 | C | INEXIUM | ESOMEPRAZOLE | 1 | 1 DF | 0 | 1 | MG | TABLET | QD | |||||||
| 126362361 | 12636236 | 9 | C | PRETERAX | INDAPAMIDEPERINDOPRIL | 1 | 1 DF (2 MG/0.0625 MG) | 0 | 1 | DF | TABLET | QD | |||||||
| 126362361 | 12636236 | 10 | C | SPECIAFOLDINE | FOLIC ACID | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126362361 | 12636236 | 11 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | 1 DF | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126362361 | 12636236 | 1 | Depression |
| 126362361 | 12636236 | 2 | Product used for unknown indication |
| 126362361 | 12636236 | 3 | Ischaemic stroke |
| 126362361 | 12636236 | 4 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126362361 | 12636236 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126362361 | 12636236 | Haematemesis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126362361 | 12636236 | 3 | 2010 | 0 | ||
| 126362361 | 12636236 | 4 | 201411 | 20141207 | 0 |